Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Sub-registry to Observe the Effect of Alglucosidase Alfa or Avalglucosidase Alfa Treatment on Pregnancy and Infant Growth in Women With Pompe Disease

NCT00567073 is registered in ClinicalTrials.gov with Genzyme, a Sanofi Company as lead sponsor.

NCT NCT00567073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00567073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Sub-registry to Observe the Effect of Alglucosidase Alfa or Avalglucosidase Alfa Treatment on Pregnancy and Infant Growth in Women With Pompe Disease
Lead sponsor
Genzyme, a Sanofi Company
Phase
Observational
Overall status
Recruiting
Start date
June 18, 2007
Completion date
January 31, 2034
Enrollment
20 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

glycogen storage disease type ii (gsd-ii), glycogenesis 2 acid maltase deficiency, pompe disease (late-onset)